Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $36.28 Analyst target: $49.50 Upside: 36.44%
Indivior PLC, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company is headquartered in North Chesterfield, Virginia.
See the full interactive analysis & chart →Informational only — not investment advice.